Researchers at the Technion demonstrate a significant improvement in predicting the success of immunotherapy treatments. The technology developed by Prof. Yuval Shaked’s research group was patented and is undergoing a tech transfer process
Prestigious grants from the European Commission’s Horizon Europe program were awarded to two experienced Technion researchers with outstanding achievements over the past decade. Each of them will receive €2.5 million